Market Cap
N/A
Mon, 01 Jan 0001 00:00:00 GMT
Summary:
Nymox Pharmaceutical market capitalization is not available.NYMX Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | - | - | +0.8% | - |
| 6 m6 months | - | - | - | - |
| 1 y1 year | - | - | +1.1% | - |
| 5 y5 years | - | - | +57.8% | - |
NYMX Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | ||||
| 3 m | 3 months | ||||
| 6 m | 6 months | ||||
| 1 y | 1 year | ||||
| 3 y | 3 years | $171 M | $16 M | ||
| 5 y | 5 years | $330 M | $16 M | ||
| alltime | all time | $330 M | $12 M |
Nymox Pharmaceutical Market Cap History
| Date | Value |
|---|---|
| 2022 | $28.96 M(-74.0%) |
| 2021 | $111.21 M(-42.5%) |
| 2020 | $193.34 M(+23.4%) |
| 2019 | $156.68 M(+84.9%) |
| 2018 | $84.73 M(-54.5%) |
| 2017 | $186.05 M(+41.9%) |
| 2016 | $131.14 M(-7.0%) |
| 2015 | $141.00 M(+882.7%) |
| 2014 | $14.35 M(-93.2%) |
| 2013 | $210.46 M(-8.6%) |
| 2012 | $230.31 M(-15.1%) |
| 2011 | $271.20 M(+18.3%) |
| 2010 | $229.32 M(+60.8%) |
| Date | Value |
|---|---|
| 2009 | $142.65 M(+39.0%) |
| 2008 | $102.61 M(-39.3%) |
| 2007 | $169.15 M(+75.7%) |
| 2006 | $96.30 M(+71.6%) |
| 2005 | $56.13 M(-21.7%) |
| 2004 | $71.67 M(-13.1%) |
| 2003 | $82.48 M(+3.8%) |
| 2002 | $79.42 M(-8.7%) |
| 2001 | $86.96 M(+110.0%) |
| 2000 | $41.42 M(-24.7%) |
| 1999 | $55.01 M(-44.2%) |
| 1998 | $98.64 M(-21.6%) |
| 1997 | $125.77 M |
FAQ
- What is the all time high market cap for Nymox Pharmaceutical?
What is the all time high market cap for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high market capitalization is $329.91 M